Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?

Trends in Microbiology
Timothy J Foster

Abstract

The use of β-lactam antibiotics to treat infections caused by Staphylococcus aureus has been severely compromised by the acquisition by horizontal gene transfer of a gene that encodes the β-lactam-insensitive penicillin-binding protein PBP2a. This allows methicillin-resistant S. aureus (MRSA) to proliferate in the presence of β-lactam antibiotics. Paradoxically the dependence on PBP2a for the essential transpeptidase activity in cell wall peptidoglycan biosynthesis is the 'Achilles heel' of MRSA. Compounds that disrupt the divisome, wall teichoic acid, and functional membrane microdomains act synergistically with β-lactams against MRSA. These include drugs such as statins that are widely used in human medicine. The antibiotics vancomycin and daptomycin are also synergistic with β-lactams, and combinations have been employed to treat persistent MRSA infections. An additional benefit of exposing MRSA to β-lactams could be a reduction in virulence mediated by interfering with the global regulator Agr. The mechanistic basis of synergy is discussed, and the possibility that β-lactams can be resurrected to combat MRSA infections is explored.

Citations

Jan 10, 2019·The Journal of Biological Chemistry·Giampiero PietrocolaPietro Speziale
Jul 6, 2019·Chemical Communications : Chem Comm·Apurva PanjlaSandeep Verma
Nov 21, 2019·Protein Science : a Publication of the Protein Society·Jed F Fisher, Shahriar Mobashery
May 22, 2020·Journal of Food Protection·Joelza Silva CarvalhoRogeria Comastri DE Castro Almeida
Aug 14, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah C J JorgensenMichael J Rybak
Aug 20, 2019·The Journal of Antibiotics·Neil P J PricePatrick F Dowd
Jan 31, 2020·The FEBS Journal·Sonia HuecasJosé M Andreu
Dec 8, 2020·European Journal of Medicinal Chemistry·Yujie GaoQiang Peng
Dec 30, 2020·Chemical Reviews·Jed F Fisher, Shahriar Mobashery
May 29, 2021·Frontiers in Molecular Biosciences·Jessica R Willdigg, John D Helmann
Jul 3, 2021·Pharmaceuticals·Roxana JijieCaterina Faggio
Nov 9, 2019·Journal of Agricultural and Food Chemistry·Shuai-Cheng WuJian-Zhong Shen
Aug 16, 2019·ACS Medicinal Chemistry Letters·Enrico SperiShahriar Mobashery
Sep 14, 2021·Journal of Medicinal Chemistry·Rachit SapraV Haridas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.